Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAH8 divergent transcript (DNAH8-DT) is a long non-coding RNA gene annotated in human genome databases, mapped near the DNAH8 protein-coding locus. It does not encode any protein and is not implicated as a receptor, enzyme, transporter, or therapeutic target. There are no published reports associating DNAH8-DT with molecular functions, disease roles, or therapeutic strategies[4]. DNAH8-DT is not the same as DNAH8 (Dynein Axonemal Heavy Chain 8), which is a well-studied protein-coding gene involved in cilia and flagella motility, male infertility, and certain diseases[1][2][3]. There is no evidence that DNAH8-DT is a receptor, transporter, enzyme, or a therapeutic target via drugs or other modalities[4]. The query refers specifically to DNAH8 divergent transcript (DNAH8-DT), not the protein-coding DNAH8 gene. If information on the protein-coding DNAH8 gene is needed, that target has significant literature pertaining to male infertility (multiple morphological abnormalities of sperm flagella), motile cilia function, and possible cancer roles[1][2][3]. However, for DNAH8-DT, available data is limited to basic genomic annotation as a non-coding RNA[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAH8 divergent transcript (DNAH8-DT).